Fine Specificity of Antibody Recognition may Predict Amino Acid Substitution in the Third Variable Region of gp120 during HIV Type 1 Infection
- 1 October 1995
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 11 (10) , 1153-1162
- https://doi.org/10.1089/aid.1995.11.1153
Abstract
To investigate how human immunodeficiency virus type 1 (HIV-1) escapes from antibodies directed against the neutralization domain in the third variable region (V3) of gp120, we examined precisely which amino acid contributed to antibody binding. From six HIV-1-infected individuals, sequential sera were tested for antibody binding to individually designed peptide panels. Each individual panel contained all V3 domain sequences of cloned HIV-1 variants obtained at several time points from the studied individual. We showed that the V3 domain is a major site for escape of the humoral immune response. We showed antibody binding was reduced by certain mutations in the V3 domain and sometimes concerted mutations rendered very distinct antigenic variants. The position and the number of the mutations that occurred during infection corresponded with the position and number of amino acids in the V3 domain that were important for binding to anti-V3 antibodies in the early immune response. The specificity of the antibody binding hardly changed during infection. Although mutations at several positions of the V3 domain reduced antibody binding, the mutations were limited to certain positions, probably because the function of the region has to be maintained. The amino acids that were important for binding in combination with the preference for changes at certain positions predicted to some extent the mutations that occurred later during infectioKeywords
This publication has 44 references indexed in Scilit:
- Characterization of the Specificity of the Human Antibody Response to the V3 Neutralization Domain of HIV-1AIDS Research and Human Retroviruses, 1992
- Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1Archiv für die gesamte Virusforschung, 1992
- Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1Science, 1991
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- Failure of Zidovudine Prophylaxis after Accidental Exposure to HIV-1New England Journal of Medicine, 1990
- Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell LinesAIDS Research and Human Retroviruses, 1990
- Characterization of HIV-1 neutralization escape mutantsAIDS, 1989
- Specificity and Function of the Individual Amino Acids of an Important Determinant of Human Immunodeficiency Virus Type 1 that Induces Neutralizing ActivityJournal of General Virology, 1989
- Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope geneCell, 1988
- HTLV-III/LAV Infection in Nine Children Infected by a Single Plasma Donor: Clinical Outcome and Recognition Patterns of Viral ProteinsThe Journal of Infectious Diseases, 1986